A Phase 1 Study of the Safety and Tolerability of CTX-10726
A Phase 1 Study of the Safety and Tolerability of CTX-10726
Recruiting · NCT07419841 · Registry updated 2026-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Study of the Safety and Tolerability of CTX-10726 | Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Liver Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, endometrium neoplasm, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, hepatocellular carcinoma, kidney cancer, kidney disorder, liver disorder, neoplasm, renal cell carcinoma, urinary system disorder, uterine disorder | Recruiting | Phase 1 | 2026-10-02 | NCT07419841 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Compass Therapeutics | 6 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic Arizona | Phoenix | United States | 55 |
| Mayo Clinic Florida | Jacksonville | United States | 105 |
| Mayo Clinic Rochester | Rochester | United States | 133 |
| Nebraska Cancer Specialists | Omaha | United States | 40 |
| Prisma Health Cancer Institute | Greenville | United States | 13 |
| Scri Oncology Partners | Nashville | United States | 156 |
| START New York | Lake Success | United States | 5 |
| UPMC Hillman Cancer Center | Pittsburgh | United States | 6 |